Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 22, 2026
TickeronGET DAILY SIGNALS
Why Is Auna S.A. (AUNA) Stock Down -14.6% Today?

Why Is Auna S.A. (AUNA) Stock Down -14.6% Today?

Key Takeaways

  • Shares of AUNA tumbled roughly 14.6%, falling to about $4.62 from a prior close of $5.41.
  • The primary catalyst was a sharp cut to the company's full-year 2026 Adjusted EBITDA guidance.
  • Management now expects Adjusted EBITDA to be broadly flat year over year, down from prior guidance of 10% to 14% FX-neutral growth.
  • The revision stems from unexpected advanced-stage cancer cases under a specific Colombia payor contract, creating temporary cost pressure.
  • Full-year revenue guidance was maintained at roughly 12% FX-neutral growth, supported by a recovery in Mexico.
  • Traders are watching the upcoming third-quarter earnings call for more detail on the Colombia contract's impact.

Opening Summary

Auna S.A. (AUNA), a Latin American healthcare platform operating hospitals, clinics, and health plans across Mexico, Peru, and Colombia, saw its stock plunge in Thursday's session after the company slashed its 2026 Adjusted EBITDA outlook. The shares fell approximately 14.6%, dropping to about $4.62 from the previous session's closing price of $5.41. Markets pointed to the guidance downgrade — driven by unexpected cost pressure tied to a Colombian payor contract — as the immediate reason for the sell-off.

Guidance Cut: The Core Catalyst

The decisive driver of the decline was Auna's announcement that it now expects consolidated Adjusted EBITDA to be broadly stable year over year for 2026, a sharp downgrade from its earlier guidance of 10% to 14% growth on an FX-neutral basis. The revision follows an unexpectedly high incidence of advanced-stage cancer cases within a covered population under a specific payor contract in Colombia, which has created additional temporary cost pressure for the company.

The move represents a step down from signals management had already given during its second-quarter earnings call, when it indicated full-year Adjusted EBITDA growth was expected to land at the lower end of guidance excluding one-time effects. The further cut caught investors off guard, triggering a broad repricing of the stock.

Revenue Guidance Held, Mexico Recovery Intact

Despite the profit warning, Auna maintained its full-year 2026 revenue guidance of approximately 12% FX-neutral growth. The company attributed that confidence to a continued strong recovery in its Mexico operations during the second half of the year, with recently disclosed operating KPIs reflecting favorable volume and specialty-service trends in the third quarter.

Capital expenditures also remain within the previously communicated range of roughly 4.0% of consolidated revenue, and the company said free cash flow and leverage continue to evolve favorably. Those stabilizing factors, however, were not enough to offset investor concern over the profitability reset in Colombia.

Market Context and Trading Activity

The stock's decline came on a day when Auna was also hosting its 2026 Investor Day, at which management discussed its long-term strategy across Mexico, Peru, and Colombia. The guidance revision overshadowed the event, and selling pressure was evident from the premarket session onward, with the shares gapping down sharply before settling near the lows.

The move reflected company-specific fundamentals rather than broad sector weakness, as the negative catalyst — a contract-driven cost surprise — was idiosyncratic to Auna's Colombian operations. Management noted it is still completing its review of the payor contract's implications for full-year Adjusted EBITDA, leaving some uncertainty about whether further adjustments could follow.

What Comes Next for AUNA

Investors will now focus on Auna's third-quarter 2026 earnings call, where management has said it will provide additional detail on the Colombia payor contract and its effect on full-year Adjusted EBITDA. The company has indicated that its revenue trajectory remains intact, but the key question is whether the cost pressures prove temporary, as management described, or persist into future quarters.

Beyond the upcoming earnings report, traders will monitor the pace of Mexico's operational recovery, the stability of Auna's free cash flow and leverage metrics, and any further disclosures on the Colombia contract. The reset in guidance introduces meaningful uncertainty around near-term profitability, even as the top-line outlook remains supportive.

Trending AI Robots

For traders seeking a data-driven edge, Tickeron's Trending AI Robots page highlights AI-powered trading bots that are performing well under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, giving users a range of approaches to explore. Visit the page to see which strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AUNA

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AUNA in upward trend: price rose above 50-day moving average on October 13, 2026

AUNA moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend. In 19 of 23 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on AUNA as a result. In 37 of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for AUNA just turned positive on October 08, 2026. Looking at past instances where AUNA's MACD turned positive, the stock continued to rise in 16 of 21 cases over the following month. The odds of a continued upward trend are 76%.

The 10-day moving average for AUNA crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +2.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where AUNA advanced for three days, in 72 of 116 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The 10-day RSI Indicator for AUNA moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator moved out of overbought territory. In 7 of the 11 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

AUNA broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AUNA entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. AUNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.215) is normal, around the industry mean (204.137). P/E Ratio (24.591) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (0.289) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.07B. The market cap for tickers in the group ranges from 20.9K to 99.46B. HCA holds the highest valuation in this group at 99.46B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 21%. BMGL experienced the highest price growth at 15%, while NIVF experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -62%. For the same stocks of the Industry, the average monthly volume growth was 11% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 46
Price Growth Rating: 52
SMR Rating: 66
Profit Risk Rating: 86
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
AUNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Industry
N/A
Address
No. 6, rue Jean Monnet
Phone
N/A
Employees
15254
Web
https://www.auna.org
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.
Why Is Auna S.A. (AUNA) Stock Down -14.6% Today?